Stocktoria
Immunovant, Inc. IMVT
Nasdaq · XNAS · stock · Biological Products, (No Diagnostic Substances) · website · IPO 2019-05-14
Immunovant, Inc. institutional holders (13F)
| Investor | Shares | Value |
|---|---|---|
| BlackRock Finance, Inc. | 4,916,127 | $129.8M |
| CITADEL ADVISORS LLC | 217,298 | $5.4M |
| RENAISSANCE TECHNOLOGIES LLC | 192,500 | $4.8M |
Source: SEC EDGAR filings · CIK 0001764013 · as of 2026-03-31. Facts from filings plus Stocktoria's own computed scores — not investment advice.